Nautilus Biotechnology
Yahoo Finance • 14 days ago
Nautilus Biotechnology Q1 Earnings Call Highlights
Nautilus Biotechnology logo Key Points Management reaffirmed a commercialization timetable with the Voyager Platform targeted for pre-orders in late 2026, customer installations beginning in early 2027 and broad availability in H1 2027,... Full story
Yahoo Finance • 14 days ago
Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.02
* Nautilus Biotechnology press release [https://seekingalpha.com/pr/20490057-nautilus-biotechnology-reports-first-quarter-2026-financial-results] (NAUT [https://seekingalpha.com/symbol/NAUT]): Q1 GAAP EPS of -$0.12 beats by $0.02. * Ca... Full story
Yahoo Finance • 3 months ago
Jefferies Upgrades BETA Technologies, Inc. (BETA) to Buy
BETA Technologies, Inc. (NYSE:BETA) is among the 11 Newly-Listed NYSE Stocks to Buy Now.Jefferies Upgrades BETA Technologies, Inc. (BETA) to Buy On February 11, 2026, Jefferies analyst Sheila Kahyaoglu upgraded BETA Technologies, Inc. (NY... Full story
Yahoo Finance • 3 months ago
3 Penny Stocks With Market Caps Over $50M To Watch
As February begins, major U.S. stock indexes have surged, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. This optimistic start to the month highlights a market environment where investors are... Full story
Yahoo Finance • 6 months ago
Nautilus (NAUT) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool. Date Tuesday, Oct. 28, 2025, at 8:30 a.m. ET Call participants Chief Executive Officer — Sujal PatelChief Marketing Officer — Kentaro SuzukiChief Financial Officer — Anna Mowry Need a quote from a Motley... Full story
Yahoo Finance • 9 months ago
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June... Full story
Yahoo Finance • 3 years ago
Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming B... Full story
Yahoo Finance • 4 years ago
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financia... Full story
Yahoo Finance • 4 years ago
Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development
SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointments of Gw... Full story
Yahoo Finance • 4 years ago
Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financi... Full story
Yahoo Finance • 4 years ago
Nautilus Biotechnology to Present at EuPA and AACR Meetings
• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) • Associate Director Greg Kapp, Ph.D., to present poster at American Association for Cancer Research... Full story